VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy - Concepedia

Concepedia

Publication | Open Access

VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

DOI Full Paper Access

225

Citations

36

References

2008

Year

Alexander H. R. Varey, E S Rennel, Yan Qiu, Heather S. Bevan, R. M. Perrin, S Raffy, AR Dixon, C Paraskeva, O Zaccheo, A. Bassim Hassan,

British Journal of Cancer

References

	Year	Citations

Page 1